| Name | NH2-methylpropanamide-Exatecan TFA |
|---|---|
| Synonyms | Propanamide, 3-amino-N-[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]-2-methyl-, (2S)-, 2,2,2-trifluoroacetate (1:1) |
| Description | NH2-methylpropanamide-Exatecan TFA is a methylpropanamide-modified Exatecan (HY-13631), which is the common ADC Cytotoxin used in the synthesis of ADC. Exatecan is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research[1]. |
|---|---|
| Related Catalog | |
| Target |
Topoisomerase I[1] |
| References |
| Molecular Formula | C30H30F4N4O7 |
|---|---|
| Molecular Weight | 634.58 |